Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Tech Licenses PCR Patent From Utah Research Foundation

NEW YORK (GenomeWeb News) — Idaho Technology today said it has licensed PCR-amplification technology from Utah Research Foundation.
 
Idaho Tech said it has retained exclusive rights to the university’s Patent No. 7,160,998, entitled "Monitoring Amplification with FRET Probes,” which covers real-time PCR amplification kits using two DNA probes labeled with fluorescent molecules.
 
When these probes are hybridized to specific regions of DNA they create a fluorescent resonance energy transfer, or FRET, according to Idaho Tech.
 
Idaho Tech said it will use the technology in freeze-dried reagents that detect pathogens on its Ruggedized Advanced Pathogen Identification Device and Roche’s LightCycler instrument.
 
Financial terms of the license were not released.
 
On Jan. 5 Idaho Tech licensed PCR patents from Roche that it plans to use in its in vitro diagnostic products.
 
Six days later the company pocketed $3.5 million from Cephied as part of a settlement and a cross-licensing agreement that resolved a 2005 suit alleging that Cepheid infringed three PCR-related patents.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.